Latest Insights on GNE
Make 35% by July 4 With Exxon Mobil February 5, 2020 American Investor Today, Oil Wall Street is dumping this energy giant over a tough quarter. John Ross shares how to make 26% on Exxon's rally by Independence Day.
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
No Fear Here: 4 Stocks to Beat the Wuhan Virus January 31, 2020 2020 Financial Crisis, Great Stuff Friday Four Play: The “Fear Inoculum” Edition (Did a friend forward you this email? If so, you owe them big-time! Seriously, this is Great Stuff. We don’t take that title lightly. After you’ve thanked your friend profusely, why not sign up for yourself today? It’s mostly painless. I promise.) The Wuhan coronavirus is officially a […]
Scared Money Is Selling Oil — How to Profit in February January 29, 2020 American Investor Today, Commodities, Oil Fear around the spread of the coronavirus is pushing oil prices lower. But there are signs that oil will rebound. John Ross shares how to grab double-digit gains on oil’s rally by March.
Is Boeing Stock Too Big to Fail? January 28, 2020 American Investor Today, Investing, Stocks Boeing is working to recover from its recent crises with its new CEO. He wants to turn the company around by delivering more 737s before year’s end. I take a look at Boeing’s balance sheet and other data to let you know whether you should bet on a surge … or expect the stock to plummet even further.MEET OUR EXPERTS
Chief Investment Strategist of Money & Markets
Research Analyst
Chief Strategist of Strategic Fortunes and three elite services
Director of VIP Services
Founder of TRADEMONSTER.ai
Founder of Weekend Trader
